Clinical Trials Sponsored by Relievant Medsystems

Total 52 results

Relievant Medsystems, Inc.

Completed

Five-Plus Year Follow-Up of SMART Randomized Controlled Trial (SMART)

Chronic Low Back Pain

United States
Relievant Medsystems, Inc.

Withdrawn

Intraosseous Basivertebral Nerve Ablation for the Treatment of Chronic Low Back Pain (CLBP)

Chronic Low Back Pain

United States
Relievant Medsystems, Inc.

Withdrawn

Intraosseous Basivertebral Nerve Ablation for Treatment of Chronic Low Back Pain (CLBP)

Chronic Low Back Pain

United States
Relievant Medsystems, Inc.

Completed

SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain (SMART)

Low Back Pain

United States
Relievant Medsystems, Inc.

Completed

INTRACEPT: Prospective, Randomized, Multi-center Study Intraosseous Basivertebral Nerve Ablation for Treatment of CLBP (CLBP)

Chronic Low Back Pain

United States
Relievant Medsystems, Inc.

Completed

Study of Basivertebral Nerve Ablation Treatment of Chronic Low Back Pain

Chronic Low Back Pain

United States
University of Utah
Relievant Medsystems

Active, not recruiting

Intracept Intraosseous Basivertebral Nerve Ablation

Low Back Pain

United States
Relievant Medsystems, Inc.
M Squared Associates,Inc.

Terminated

The Intracept Global Registry ( TIGR ) - Pilot Study

Low Back Pain

United States
Relievant Medsystems, Inc.
M Squared Associates,Inc.; ProPharma Group

Completed

CLBP Single-Arm Long-Term Follow-up Study

Chronic Low Back Pain

United States
EP MedSystems

Completed

Intra-Cardiac Echocardiography Guided Cardioversion(ICE-CHIP) Study (ICE-CHIP)

Atrial Fibrillation

United States, Netherlands
Conor Medsystems

Terminated

CoStar Catheter System Evaluation (CONCISE)

Symptomatic Ischemic Heart Disease

Germany
Conor Medsystems

Terminated

Reduced Anti-Platelet Therapy With Pimecrolimus Drug Eluting Stent (RAPID)

Coronary Disease

Brazil
Conor Medsystems

Completed

CoStar™ Paclitaxel-Eluting Coronary Stent Catheter System Evaluation

Coronary Disease

Belgium
Channel Medsystems

Recruiting

A Registry to Gather Real World Use Data on the Cerene® Cryotherapy Device (Progress)

Menorrhagia | Heavy Menstrual Bleeding | Abnormal Uterine Bleeding

United States
Channel Medsystems

Completed

A CLinical Study to Evaluate the Safety And Effectiveness of the CeRene DevIce to Treat HeavY Menstrual Bleeding (CLARITY)

Menorrhagia

United States, Canada, Mexico
Conor Medsystems

Terminated

Prospective, Multi-Center, Random. Study of CoStar Paclitaxel-Eluting Coronary Stent(Direct Stenting vs. Pre-Dilatation) (DECIDE)

Coronary Artery Disease

Germany
Mercator MedSystems, Inc.

Unknown

Lower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Atherectomy (ATX)-Based Revascularization (LIMBO-ATX)

Chronic Limb Ischemia

United States
Mercator MedSystems, Inc.

Recruiting

Temsirolimus Alone or Paired With Dexamethasone Delivered to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization (TAP-DANCE)

Peripheral Arterial Disease

United States
Mercator MedSystems, Inc.

Unknown

Temsirolimus Adventitial Delivery to Improve Angiographic Outcomes Below the Knee (TANGO) (TANGO)

Chronic Limb Ischemia

United States
Mercator MedSystems, Inc.

Unknown

Lower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Percutaneous Transluminal Angioplasty Revascularization (LIMBO-PTA)

Chronic Limb Ischemia

Germany
Cordis Corporation
Conor Medsystems

Completed

The European Cobalt STent With Antiproliferative for Restenosis Trial (EuroSTAR Trial)

Treatment of Symptomatic Ischemic Heart Disease

Italy
Mercator MedSystems, Inc.

Not yet recruiting

Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee (TANGO-3)

Peripheral Artery Disease | Critical Limb Ischemia
Mercator MedSystems, Inc.

Completed

Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease (DANCE)

Peripheral Arterial Diseases

United States
Mercator MedSystems, Inc.

Completed

DANCE Partner: Inflammatory Biomarker Analysis by Femoropopliteal Revascularization Method and Treatment Outcomes

Peripheral Arterial Disease

United States
Cordis Corporation
Conor Medsystems

Completed

Cobalt Chromium Stent With Antiproliferative for Restenosis II Trial (COSTAR II)

Coronary Disease

United States
Conor Medsystems
Getz Pharma

Terminated

Multi-Center Clinical Trial: Evaluation of Effectiveness and Safety

Coronary Disease

Japan
Cordis Corporation
Conor Medsystems

Completed

A Randomized, Multi-Center Study of the Pimecrolimus-Eluting and Pimecrolimus/Paclitaxel-Eluting Coronary Stent Systems (GENESIS)

Coronary Disease

United Kingdom
Cordis Corporation
Conor Medsystems

Terminated

Comparison of the Conor Sirolimus-eluting Coronary Stent to the Taxus Liberte Paclitaxel-eluting Coronary Stent in the Treatment of Coronary Artery Lesions (NEVO RES-I)

Coronary Atherosclerosis

Brazil, New Zealand
Cordis Corporation
Conor Medsystems

Terminated

Conor Cobalt Chromium Reservoir Based Stent With Sirolimus Elution in Native Coronary Artery Lesions (NEVO RES-II)

Coronary Disease

Germany, Latvia
Heidelberg Metasystems GmbH

Unknown

Observational Study Regarding Adherence, Drug Use, Will to Take Part in Shared Decisioning in Asthma Outpatients

Asthma

Germany
Invitrox
Reliant Pharmaceuticals

Completed

Lovaza's Effect on the Activation of Platelets (LEAP)

Cardiovascular Disease | Bleeding
Mercator MedSystems, Inc.
National Cancer Institute (NCI)

Completed

Broncho-Adventitial Delivery of Paclitaxel to Extend Airway Patency in Malignant Airway Obstruction Patients (BROADWAY)

Malignant Airway Obstruction Secondary to Non-small Cell Lung Cancer

United States
University of Washington
Revivant Corporation

Terminated

AutoPulse Assisted Prehospital International Resuscitation Trial (ASPIRE)

Cardiac Arrest

United States
Penn State University
Reliant Pharmaceuticals

Completed

Vascular and Lipid Effects of Omega-3 Fatty Acids in People With Moderately Elevated Triglycerides (OMEGA)

Hypertriglyceridemia

United States
University of Arizona
Reliant Pharmaceuticals

Withdrawn

Omacor for Perimenopausal Depression

Depression

United States
Provident Clinical Research
Reliant Pharmaceuticals

Completed

An Evaluation of Simvastatin Plus Omacor Compared to Simvastatin Plus Placebo in Subjects With Mixed Dyslipidemia

Mixed Dyslipidemia
University of Virginia
Reliant Pharmaceuticals

Withdrawn

Lovaza Therapy of Peripheral Arterial Disease

Peripheral Artery Disease

United States
Provident Clinical Research
Reliant Pharmaceuticals

Unknown

An Open-Label Extension to Assess the Continued Efficacy of Omacor Plus Simvastatin

Mixed Dyslipidemia
University of Massachusetts, Worcester
Pfizer; Reliant Medical Group

Completed

System Alignment for VaccinE Delivery (SAVED): Improving Rates of Influenza and Pneumococcal Vaccination Through Patient Outreach, Improved Medical Record Accuracy and Targeted Physician Alerts

Influenza | Infections, Pneumococcal

United States
Olive View-UCLA Education & Research Institute
Reliant Pharmaceuticals

Completed

The Effect of Fish Oil Supplementation on Endothelial Function, Heart Rate Variability and Intimal Media Thickness of Patients With Coronary Artery Disease

Coronary Artery Disease

United States
McMaster University
College of Family Physicians of Canada; MediSystem Pharmacy

Unknown

Deprescribing Antipsychotics in Long-Term Care

Dementia | Behavior

Canada
University of Massachusetts, Worcester
University of Massachusetts, Amherst; Reliant Medical Group

Completed

CONtrolling Disease Using Inexpensive IT - Hypertension in Diabetes (CONDUIT-HID)

Hypertension | Diabetes Mellitus

United States
University of California, Irvine
University of Minnesota; Reliant Technologies, Inc. Mountain View, CA

Completed

Fractional Resurfacing Device for Treatment of Acne Scarring

Scar | Acne

United States
University of Massachusetts, Worcester
Agency for Healthcare Research and Quality (AHRQ); Reliant Medical Group

Completed

Improving Safety After Hospitalization in Older Persons on High-Risk Medications

Medication Safety
University of Missouri, Kansas City
Reliant Pharmaceuticals; Saint Luke's Health System Foundation; Truman Medical...

Withdrawn

Use of Omega-3 Fatty Acids (Fish Oil) in Patients With Chronic Hepatitis C Infection

Hepatitis C

United States
Washington University School of Medicine
Reliant Pharmaceuticals; Longer Life Foundation; American Federation for Aging...

Completed

Omega-3 Fatty Acids and Muscle Protein Synthesis

Healthy

United States
University of Massachusetts, Worcester
National Cancer Institute (NCI); Reliant Medical Group; Fallon Community Health...

Completed

Promoting Breast Cancer Screening in Non-adherent Women

Breast Cancer

United States
University of California, San Diego
Patient-Centered Outcomes Research Institute; University of Massachusetts,... and other collaborators

Completed

OPEN & ASK: Improving Patient-Centered Communication in Primary Care

Patient Engagement | Physician-Patient Relations | Physician's Role | Patient Activation

United States
DARTNet Institute
University of Colorado, Denver; Icahn School of Medicine at Mount Sinai; Brigham... and other collaborators

Recruiting

Individualizing Treatment for Asthma in Primary Care (iTREAT-PC)

Respiratory Tract Infections | Immune System Diseases | Lung Diseases | Bronchial Diseases | Lung Diseases, Obstructive | Asthma | Respiratory Hypersensitivity

United States
Mercator MedSystems, Inc.
University of South Florida; Northwestern University; Stony Brook University; Guy... and other collaborators

Recruiting

Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Acute Femoropopliteal DVT (DEXTERITY-AFP)

Thrombosis, Deep Vein | Iliofemoral; Thrombosis

United States, Ireland, United Kingdom

Clinical Trials Sponsored by Relievant Medsystems

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Oman

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations